Summit Therapeutics, Inc. (SMMT)
15.46
-0.14
(-0.90%)
USD |
NASDAQ |
Mar 19, 10:44
Summit Therapeutics EPS Diluted (Quarterly) : -0.286 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Revolution Medicines, Inc. | -1.855 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Exelixis, Inc. | 0.8849 |
| Insmed, Inc. | -1.538 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -219.17M |
| Total Expenses (Quarterly) | 219.17M |
| Enterprise Value | 11.40B |
| Earnings Yield | -9.35% |
| Normalized Earnings Yield | -9.345 |